Pan-European First of the Athens Medical Center in Research Treatment for Prostate Cancer
At the Athens Medical Center, within the framework of an international clinical study, an investigational treatment was administered for the first time in Europe to a patient with metastatic castration-resistant prostate cancer.
The administration of the treatment was carried out under the coordinating role of Dr. Marinos Tsiatas, Oncologist and Director of the Oncology Clinic of the Athens Medical Center, confirming the leading role of the Athens Medical Center in the implementation of innovative therapeutic interventions in the field of oncology.
As Dr. Marinos Tsiatas explains: “Our participation in this important international clinical study and the first administration of the investigational treatment to a patient in Europe, underline our commitment to promoting research and providing access to innovative treatments for our patients. We are proud that Athens Medical Center is at the forefront of clinical research against cancer.”
Athens Medical Center is a reference point in Clinical Research, consistently participating in numerous international and multicenter Phase II and III clinical studies. Through strategic partnerships with leading global research institutions and pharmaceutical companies, the hospitals of the Athens Medical Group offer patients access to innovative, under-study therapies, combining scientific pioneering with high-level, personalized medical care.
Info: This specific therapy is in the research stage and has not yet received approval from the Hellenic Medical Authority or the EMA.
